************************************************************** Mach7 announces $3.7 million deal
Imaging company Mach 7 Tech (ASX:M7T) also rose 5% this morning after announcing a 5-year subscription licence to provide eUnity to Diagnostic Imaging Associates (DIA).
The contract replaces small use case Client Outlook mammography contract, and is worth $3.7 million in TCV and $0.64 million to Annual Recurring Revenue (ARR).
The deal further is set to expand Mach7’s footprint in the outpatient/teleradiology marketplace.
CEO of Mach7, Mike Lampron, said market research continues to evidence a dynamic shift in where and how patients want to receive healthcare.
He also said that DIA is a large, growing practice that is benefiting from the shift in diagnostic imaging from acute care to ambulatory settings.
“We are delighted to now provide its 70-strong radiologist practice with the full functionality of our zero-footprint eUnity Diagnostic Viewer.”
M7T Price at posting:
95.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)